Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients
Top Cited Papers
Open Access
- 15 June 2004
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 172 (12), 7335-7340
- https://doi.org/10.4049/jimmunol.172.12.7335
Abstract
NK cell function in cancer patients is severely impaired, but the mechanism underlying this impairment is not clearly understood. In this study we shoKeywords
This publication has 33 references indexed in Scilit:
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- Significance of transforming growth factor β1 as a new tumor marker for colorectal cancerInternational Journal of Cancer, 2001
- ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cellsEuropean Journal of Immunology, 2001
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORSAnnual Review of Immunology, 1999
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993